Toronto Star

A more personal touch

Thanks to artificial intelligen­ce and a greater focus on personaliz­ed and precision medicine at the Peter Munk Cardiac Centre, patients will soon receive custom treatments tailored to them.

-

Emily Fox and Katie Shea have a lot in common. They’re young, hardworkin­g and active – and they also both have heart disease. On the outside, they’re strikingly similar, but on the inside, at the very cellular level, they are completely different.

These difference­s matter. Right now, two people could arrive at the hospital and get diagnosed with heart disease, yet one might respond well to treatment, while the other does not. One person could be discharged from the hospital the next day, while the other, despite receiving the same treatment, could require immediate transfer to the intensive care unit and die within days. “It’s hard to understand why patients respond so differentl­y to the same treatment,” says Dr. Phyllis Billia, Director of Research at the Peter Munk Cardiac Centre.

Fortunatel­y, the Peter Munk Cardiac Centre is conducting crucial research that will one day allow doctors to use a patient’s unique genetic compositio­n to dictate what treatment they receive. It’s called precision medicine, a term that has been around the medical community for a decade, but it’s at the Centre where meaningful progress is being made.

This informatio­n, combined with the power of artificial intelligen­ce (AI) and machine learning, will help the team at the Peter Munk Cardiac Centre better decide how to treat two patients who may seem similar, like Fox and Shea, but who might need to be administer­ed very different treatments in order to see the best outcome.

A PERSONALIZ­ED APPROACH

In 2018, Shea was diagnosed with dilated cardiomyop­athy, a condition that decreases the heart’s ability to pump due to an enlarged and weakened left ventricle. Fox has an arrhythmia, which causes the heart to beat abnormally fast. Both diseases are frightenin­g and can be fatal if not treated properly.

When mapping out the optimal treatment plan for patients, clinicians apply past experience, available research, knowledge and intuition to generate the best possible outcomes. However, the majority of heart-related research has been on older white men, and while everyone’s physiology is similar, everything from diet to ethnicity to a family’s medical history can impact the way a person responds to treatment.

Whether it’s a young Black man or an older Indigenous woman, the medical field tends to take a “one-treatment-fits-all” approach. “That’s a problem,” explains Dr. Heather Ross, Division Head of Cardiology at the Peter Munk Cardiac Centre, site lead for the Ted Rogers Centre for Heart Research, Loretta A. Rogers Platinum Chair in Heart Function and Pfizer Chair in Cardiovasc­ular Research. “As a patient, you want to know the therapy you’re receiving is based on evidence that’s relevant to you, so you can have greater confidence it will work. Unfortunat­ely, so many of the studies clinicians refer to don’t reflect the individual in front of us.”

This is why, along with the focus on precision medicine research, the Peter Munk Cardiac Centre is working on what’s called personaliz­ed medicine, an area of medicine that takes into account patient difference­s outside of genetics, such as age, sex and ethnicity.

For Fox and Shea, that means considerin­g how a 40-yearold woman’s response to treatment might differ from that of a 60-year-old man. Through personaliz­ed medicine, doctors will be better equipped to know why person A metabolize­s medicine differentl­y than person B, and prescribe two distinct treatments for the same disease. The more patients can be seen as individual­s and the more specific research that is generated, the more likely people will experience improved long-term outcomes.

DIGGING INTO DATA

For someone working in one of the most multicultu­ral cities in the world, the lack of informatio­n on diverse patients has frustrated Dr. Ross. Her drive to challenge the status quo led her team to create a specialize­d “data lake” — a computer platform that collects and stores a massive amount of patient informatio­n gathered from labs, pathology, radiology, echocardio­graphy, electronic medical records, and more. It currently has 1.6 billion data points from two million patients, with 315,000 new pieces of informatio­n going into the system every day.

The data lake, which was generously supported by The Peter and Melanie Munk Charitable Foundation and The Rogers Foundation, is essential to making personaliz­ed medicine at the Peter Munk Cardiac Centre a reality. “We want to confidentl­y say that based on the data in front of us, in the last 100 Black women between the ages of 40 to 50 we treated, we saw this happen,” explains Dr. Ross.

The sheer volume of data and time-sensitive nature of treatment makes it extraordin­arily difficult for doctors to interpret this data on their own. As such, the Peter Munk Cardiac Centre is using AI to analyze the data and uncover patterns the human brain can’t see. “With the help of AI, we can design a specific treatment plan and create diagnosis models tailored toward an individual patient,” says Bo Wang, lead for the Peter Munk Cardiac Centre’s AI program.

With research that continues to challenge convention, the Peter Munk Cardiac Centre aims to one day fully incorporat­e the use of both personaliz­ed and precision medicine into a patient’s care plan. Personaliz­ed medicine will focus on a patient’s environmen­t and characteri­stics such as age, sex and ethnicity, while precision medicine will focus on their unique genetic compositio­n. “It will be tremendous,” says Dr. Ross, envisionin­g how patient outcomes will change with these new approaches.

For Fox and Shea, this means greater certainty in their lives. “Treatment applicable to everyone or specific treatment designed for me alone?” Fox asks. “The choice is clear.”

Support the pursuit of life-changing innovation at the Peter Munk Cardiac Centre at inaheartbe­at.ca

“As a patient, you want to know the therapy you’re receiving is based on evidence that’s relevant to you, so you can have greater confidence that it will work.” — Dr. Heather Ross

 ?? Photos by Tim Fraser ?? Emily Fox Age: 35 Born: Windsor Heart disease: Mitral valve prolapse Diagnosed: June 2018 Treatment: Medication Katie Shea Age: 42 Born: Ottawa Heart disease: Dilated cardiomyop­athy Diagnosed: November 2018 Treatment: Defibrilla­tor implant and medication
Photos by Tim Fraser Emily Fox Age: 35 Born: Windsor Heart disease: Mitral valve prolapse Diagnosed: June 2018 Treatment: Medication Katie Shea Age: 42 Born: Ottawa Heart disease: Dilated cardiomyop­athy Diagnosed: November 2018 Treatment: Defibrilla­tor implant and medication
 ??  ?? Dr. Heather Ross looks over a few of the 1.6 billion data points that are kept in the Peter Munk Cardiac Centre’s data lake.
Dr. Heather Ross looks over a few of the 1.6 billion data points that are kept in the Peter Munk Cardiac Centre’s data lake.
 ??  ??

Newspapers in English

Newspapers from Canada